Skip to main content
P

PCL. Inc — Investor Relations & Filings

Ticker · 241820 ISIN · KR7241820000 KO Manufacturing
Filings indexed 681 across all filing types
Latest filing 2023-09-12 Share Issue/Capital Cha…
Country KR South Korea
Listing KO 241820

About PCL. Inc

http://www.pclchip.com/

PCL, Inc. is a company that develops and manufactures in-vitro diagnostic (IVD) medical devices, specializing in multiplex immunodiagnosis. The company's core offering is based on its proprietary SG Cap™ Technology, a platform for creating advanced diagnostic solutions. Its product portfolio includes automated multi-immune diagnostic systems, blood testing kits, cancer screening tests, and rapid antigen kits. PCL also provides platform services, reagents, and related equipment such as desktop arrayers to the medical and diagnostic fields.

Recent filings

Filing Released Lang Actions
증권발행결과(자율공시)(주주배정 유상증자)
Share Issue/Capital Change Classification · 1% confidence The document is a formal announcement regarding the results of a capital increase (rights offering) by PCL. It details the number of shares issued, the total amount raised, and the payment completion date. This falls under the category of share issuance and capital changes.
2023-09-12 Korean
주식등의대량보유상황보고서(일반)
Major Shareholding Notification Classification · 1% confidence The document is titled '주식등의 대량보유상황보고서' (Report on Large Shareholding of Stocks, etc.), which is the standard regulatory filing in South Korea for reporting significant changes in share ownership (often referred to as the 5% rule filing). It details the reporting entity, special related parties, changes in shareholding percentages, and the purpose of holding (management influence). This fits the definition of a Major Shareholding Notification.
2023-09-07 Korean
유상증자또는주식관련사채등의청약결과(자율공시)
Share Issue/Capital Change Classification · 1% confidence The document is a formal regulatory filing from the Korea Exchange (KRX) system regarding the results of a paid-in capital increase (rights offering) for the company PCL. It details the subscription results, including the number of shares subscribed, the subscription rate, and the handling of fractional shares. This falls under the category of capital changes and share issuance announcements.
2023-09-06 Korean
[기재정정]주요사항보고서(유무상증자결정)
Share Issue/Capital Change Classification · 1% confidence The document is a 'Major Matters Report' (주요사항보고서) regarding a decision on capital increase (both paid-in and bonus issues). It details the final issuance price, subscription dates, and allocation methods for a capital increase. This type of filing is a regulatory disclosure regarding changes in capital structure and share issuance, which falls under the 'Share Issue/Capital Change' category.
2023-08-31 Korean
[발행조건확정]증권신고서(지분증권)
Capital/Financing Update Classification · 1% confidence The document is a '증권신고서(지분증권) 정정신고서' (Amendment to Securities Registration Statement) filed with the Financial Services Commission (FSC) in South Korea. It details the finalization of the issuance price for a capital increase (rights offering). This type of regulatory filing, which provides specific details on capital structure changes and public offering terms, falls under the 'Share Issue/Capital Change' category (SHA) as it pertains to the issuance of new shares and the associated pricing mechanics.
2023-08-31 Korean
[기재정정]투자설명서
Capital/Financing Update Classification · 1% confidence The document is a 'Investment Prospectus' (투자설명서) amendment (정정신고) filed by PCL Co., Ltd. It details the finalization of the offering price for a capital increase (rights offering). This type of document is a regulatory filing related to capital raising and financing activities. According to the provided definitions, documents detailing fundraising and capital structure changes are classified as 'CAP'.
2023-08-31 Korean

Report missing filing

Can't find a specific document? Let us know and we'll add it within 24 hours.

We will notify you once the filing is added.
Report sent
Thank you. We will check the data and update it shortly.